AXAxinet
Menu
Finance

Live market screen

Commercial Space Company Risk / Opportunity Ranking

Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.

Updated June 27, 2026

Companies analyzed
438
Ranked rows
876
Evidence links
356
Rows per page
20

Opportunity view

Showing rows 161-180 of 438; 20 rows per page.

Sorted by raw opportunity score
RankCompanyScoreThesis / Evidence
161
Antaris Inc.
lowweak
Opp 2
Risk 2

Thesis: Antaris may have strategic opportunity based on the membership rationale referencing private space software work, LEO ISR/optical communications architecture, a JANUS-2 mission, and self-healing satellite capability for the U.S. Space Force, but the reviewed sources includes no retained recent evidence window-window evidence to support scoring that thesis now.

Why now: There is no retained 90-day evidence in these reviewed sources despite references to evidence in earlier processing. Recency-sensitive conclusions therefore cannot be made from the local reviewed sources.

Caveats: Membership rationale references older evidence but no article IDs are provided with accessible summaries in these reviewed sources body. No representative articles or retained evidence are included. Low score reflects evidence absence, not a negative business judgment.

162
Antaris Inc.
lowweak
Opp 2
Risk 1

Thesis: There is a faint opportunity signal because the phase2 rationale states Antaris appeared as part of an investment issuer's portfolio after a $28 million Series A, which suggests access to capital, but the reviewed sources does not provide the underlying citable event text in the scoring evidence fields.

Why now: Why now is weak: the only reviewed sources signal is the phase2 rationale mentioning a post-Series A portfolio reference tied to article, but no representative article summary or direct evidence row is included here to establish timing or business impact.

Caveats: The cited Series A context appears only in phase2 rationale rather than in stronger scoring evidence fields. No product, customer, or execution evidence is provided.

163
Applied Atomics
lowweak
Opp 2
Risk 3

Thesis: Applied Atomics may have long-horizon optionality as a startup developing in-space mobility/orbital logistics concepts, but the reviewed sources provide no available article or evidence inside the recent evidence window to support a stronger opportunity score.

Why now: There is no available dated evidence in the reviewed sources after recent evidence filtering, so recency-based ranking support is weak.

Caveats: No representative articles or evidence are available after recent evidence filtering for ranking support. The phase2 membership rationale mentions a $4M pre-seed and Star Reacher Network, but the cited supporting articles are not provided with usable article summaries or evidence in these reviewed sources.

164
Astranis Space Technologies
lowweak
Opp 2
Risk 2

Thesis: Phase-2 rationale states Astranis was selected by the U.S. Space Force for the Andromeda contract for next-generation space domain awareness/surveillance satellites, which would be positive if current and retained, but the present reviewed sources contain no in-window evidence to substantiate it.

Why now: The current batch retains no representative articles or evidence within the 90-day recent evidence window for Astranis, so the reviewed sources does not provide a current dated catalyst despite the phase-2 rationale.

Caveats: No retained evidence after recent evidence window. Phase-2 rationale mentions duplicate article versions; duplicates would not be independent confirmation anyway.

165
Astrobotic Technology
lowweak
Opp 2
Risk 2

Thesis: The membership rationale says Astrobotic operates the Griffin lunar lander and is a CLPS contractor, which is strategically relevant for a 1 year+ horizon, but the reviewed sources supplies no available within the recent evidence window direct positive evidence or dated article summaries for scoring.

Why now: The rationale references articles, and: but no corresponding available evidence remains available for direct scoring after recent evidence filtering.

Caveats: Lunar lander category fit does not equal thesis attractiveness. Coverage debug shows zero available evidence after recent evidence window. Without direct execution, funding, contract-conversion, or mission-status evidence, scores should remain conservative.

166
Astrolight
lowweak
Opp 2
Risk 1

Thesis: Membership rationale indicates Astrolight is a private space/defense startup developing laser communication terminals for space, with ESA contracts and deployed terminals, which could support a 1 year+ growth thesis in optical communications if verified by direct evidence.

Why now: Why now is weak because the reviewed sources cites support article: in membership rationale, but no, article summary, or retained evidence are provided after the 90-day filter.

Caveats: Potentially strong fundamentals are only referenced in membership rationale without citable article details. Coverage data shows zero articles after recent evidence window and zero evidence after recent evidence window. Private-company status also limits external validation in these reviewed sources.

167
Astrolight UAB
lowweak
Opp 2
Risk 2

Thesis: Astrolight UAB may have a long-horizon opportunity if it is providing optical hardware into a Kepler Communications ESA HydRON optical communications network effort, but the reviewed sources lack available direct evidence to confirm Astrolight's own contract position, scope, or recency.

Why now: There is no usable 'why now' beyond possible strategic relevance to optical communications. The reviewed sources provide no after-recent evidence window evidence to confirm current status.

Caveats: Phase-2 rationale references, but the reviewed sources does not include its or article summary. Relations marked context-only cannot be used as counterparty propagation evidence. Coverage debug shows zero evidence after recent evidence window.

168
Astrome
lowweak
Opp 2
Risk 1

Thesis: Reviewed evidence rationale says Astrome was among spacetech startups receiving India's RDI fund support, which is directionally positive as non-dilutive or supportive capital context, but no underlying article or dated event evidence is present in the available recent evidence window dataset.

Why now: Why now is weak because the support exists only in the phase-2 rationale; coverage data shows zero evidence after recent evidence window, so timing and durability of the funding support cannot be verified from local evidence.

Caveats: No direct article or event evidence is available after recent evidence window. Government-support statement is not accompanied by a dated in-window source in the reviewed sources. Low confidence due to sparse evidence.

169
Atomos Space
lowweak
Opp 2
Risk 1

Thesis: A very modest opportunity case exists only because retained undated supporting context lists Atomos Space as an operating in-orbit servicing company, which at least suggests ongoing activity in a strategically relevant segment, but this is supporting article context rather than direct company event evidence.

Why now: Why now is limited and recency is uncertain: the only retained evidence is undated supporting context, so it cannot establish a fresh catalyst, only background relevance, article date_basis: undated).

Evidence
  • Space Index lists 'Atomos Space|Broomfield, Colorado, USA|operating' within 'In-Orbit Servicing & Assembly Companies.' This is undated supporting article context, not direct event proof. spaceindex.io

Caveats: The evidence is undated, and the reviewed sources explicitly says to treat undated external evidence as relevance context rather than recency proof. The retained rows are weak context and neutral polarity, not positive evidence. Same article repeated rows are not independent confirmation.

170
Azista Space
lowweak
Opp 2
Risk 2

Thesis: Reviewed evidence membership rationale says Azista Space built the satellite bus/payload for GalaxEye's Drishti Earth Observation Satellite, which implies real manufacturing participation and possible long-horizon opportunity, but no direct evidence or article are available in the served reviewed sources.

Why now: Why now is weak because there is no surviving 90-day evidence row in the reviewed sources to establish recency or momentum.

Caveats: Only membership rationale is available; no citeable direct evidence with are provided. Single-article universe increases fragility of inference.

171
Blackstar Orbital
lowweak
Opp 2
Risk 2

Thesis: The reviewed sources rationale suggests Blackstar Orbital is described as a hypersonic/reusable spacecraft testing partner with mention of a reusable hypersonic satellite concept, which could imply technology optionality if substantiated and, no provided in reviewed sources). However, the evidence retained here is not direct and no positive events are available after recent evidence window.

Why now: No near-term or durable catalyst can be established from retained evidence because coverage debug shows zero article IDs and zero evidence after recent evidence window.

Caveats: No are provided for the cited support articles in the reviewed sources. The reviewed sources explicitly characterizes the evidence as mostly partnership context rather than direct operating detail. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0.

172
Brightside Group S.A.
lowweak
Opp 2
Risk 2

Thesis: Membership rationale indicates Brightside is advancing a €415M sovereign satellite program and provides a sovereign satellite platform via partnership with SES, which could be meaningful if current, but the reviewed sources exposes no direct within the recent evidence window evidence or article summaries to substantiate a current opportunity thesis.

Why now: Why now is weak because no representative article or direct evidence survives in the ranking fields after recent evidence window; only membership rationale references without surfaced article content.

Caveats: No direct within the recent evidence window evidence is available in ranking fields. Membership rationale alone is weaker than surfaced company-specific event evidence. No negative thesis is supportable from the reviewed sources.

173
BULL Co., Ltd.
lowweak
Opp 2
Risk 1

Thesis: The membership rationale says BULL signed an agreement with Fujitsu to develop a high-precision space situational awareness service for Japan, which is directionally positive, but there is no retained within the recent evidence window article evidence or in the reviewed sources to support a stronger opportunity thesis.

Why now: No within the recent evidence window evidence were retained, so there is no strong timing signal for a 1 year+ ranking beyond weak membership context.

Caveats: Membership rationale references articles and, but the reviewed sources does not provide or retained evidence. Potential commercial significance cannot be sized from the reviewed sources.

174
Calian Group Ltd.
lowweak
Opp 2
Risk 1

Thesis: There is some older membership support that the Canadian Space Agency awarded Calian funds for RADARSAT+ ground-segment concept studies via article: which could indicate space-contract relevance, but no retained in-window evidence with supports a stronger current opportunity thesis.

Why now: Why now is weak because the reviewed sources retained no evidence after recent evidence window for Calian, so no current catalyst is evidenced.

Caveats: Reviewed evidence mentions: but provides no, preventing direct citation as scored evidence. No retained 90-day evidence. Opportunity case depends on uncited older context rather than current business-state confirmation.

175
CAS Space
lowweak
Opp 2
Risk 3

Thesis: CAS Space may have long-horizon opportunity as a reusable rocket developer and launch provider, but the ranking reviewed sources provide no available supporting evidence within the recent evidence window.

Why now: There is no usable dated evidence available after recent evidence filtering, so the reviewed sources does not provide a clear timing catalyst.

Caveats: The membership rationale references an IPO and Lijian-1 launch activity, but those source articles are not included with ranking-usable details in these reviewed sources.

176
CAS Space
lowweak
Opp 2
Risk 2

Thesis: The reviewed sources rationale says CAS Space is among Chinese rocket/satellite companies advancing IPO or pre-IPO plans, which could be a strategic opportunity signal if supported by company-specific evidence (: and: no provided in reviewed sources).

Why now: There is no verified current catalyst in retained evidence. IPO/pre-IPO framing could matter on a 1 year+ horizon, but recency and milestone state cannot be confirmed here because no dated evidence are available after recent evidence window.

Caveats: No are provided for the cited support articles in the reviewed sources. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. IPO/pre-IPO mention is only in reviewed sources rationale, not in retained direct evidence.

177
Citra Space Corp
lowweak
Opp 2
Risk 1

Thesis: The membership rationale says Citra Space raised a $15M Series A to advance space object identification technology, which would ordinarily be positive, but the reviewed sources provide no retained within the recent evidence window article evidence or to ground a stronger opportunity call.

Why now: There is no usable within the recent evidence window article evidence available for ranking; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window, so any current catalyst judgment would be speculative.

Caveats: Membership rationale references article, but the reviewed sources does not provide the article or retained ranking evidence inside the recent evidence window. Because direct evidence arrays are empty, the small positive score reflects only weak contextual possibility, not high-confidence attractiveness.

178
Cosmoserve Space
lowweak
Opp 2
Risk 2

Thesis: Reviewed evidence membership rationale says Cosmoserve Space is a private space sustainability company working on debris removal, with Pixxel providing a satellite bus for its demo mission. That suggests a real mission path, but there are no citeable direct evidence or in the served reviewed sources.

Why now: Why now is weak because the reviewed sources does not establish current demo timing or funding status with direct evidence after recent evidence window.

Caveats: Private company with thin visible evidence in these reviewed sources. Mission/demo status cannot be validated from available evidence.

179
Curtiss-Wright Corporation
lowweak
Opp 2
Risk 1

Thesis: Curtiss-Wright has modest contextual opportunity because the membership rationale describes it as a ruggedized electronics supplier benefiting from broader space spending, which could align with a durable 1 year+ strategic cycle if backed by company-specific orders or segment growth evidence (: unavailable in reviewed sources). But the reviewed sources contain no direct positive evidence within the recent evidence window.

Why now: Potentially relevant if broader space spending is increasing, but the reviewed sources provide no retained dated evidence, no current data, so timing and magnitude cannot be validated.

Caveats: No current evidence is provided for Relation/context evidence must not be used as counterparty propagation; reviewed sources notes context only. No available direct evidence after recent evidence window despite high article count considered.

180
Deloitte
lowweak
Opp 2
Risk 1

Thesis: There is some indication of meaningful space activity, but not enough retained direct evidence to make a strong 1 year+ opportunity call.

Why now: The reviewed sources rationale says Deloitte launched satellites for Project Constellation to test on-orbit cyber protections and contracted Spire to design, build, and operate satellites, citing article, but no or retained evidence row is available after recent evidence window, limiting confidence.

Caveats: The described activity comes only from membership rationale rather than retained evidence. Without retained dated evidence or, chronology and durability cannot be tested.

Risk view

Showing rows 361-380 of 438; 20 rows per page.

Sorted by raw risk score
RankCompanyScoreThesis / Evidence
361
Safran
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources also does not provide direct adverse evidence within the available 90-day evidence set, so there is no basis for a material risk thesis beyond uncertainty from missing evidence coverage.

Why now: There is no current catalyst in the reviewed sources. Coverage debug shows 270 article IDs considered but 0 article IDs after recent evidence window and 0 evidence available after dedupe, so recency-based thesis formation is not supported.

Caveats: Membership rationale references article IDs 2026-04, and, but no are provided in the reviewed sources, so they cannot be cited as factual scoring evidence under the the evidence standard. Evidence recent evidence review shows 0 kept rows after the 90-day cutoff.

362
Sanyark Space Technologies
lowweak
Opp 2
Risk 1

Thesis: No direct negative evidence is available. Risk is mainly that accelerator inclusion alone is too weak to support a durable company thesis, especially over a 1 year+ horizon without proof of funding, contracts, or product milestones (: not provided in reviewed sources).

Why now: There is no supported timing edge because the reviewed sources have zero direct evidence after recent evidence window and no dated article details beyond the structure.

Caveats: Accelerator participation is weaker than company-specific funding or contract evidence. The article appears to describe a cohort rather than a company-specific event. No, quote, or direct event row is available.

363
SatLeo Labs
lowweak
Opp 1
Risk 1

Thesis: No material adverse evidence is available in the reviewed sources.

Why now: No retained within the recent evidence window evidence are provided, so there is no reviewed sources-supported why-now beyond cohort inclusion rationale.

Caveats: Only membership rationale is available; no citeable retained evidence. Small-company universe but zero available evidence after recent evidence window.

364
SatVu
lowweak
Opp 2
Risk 1

Thesis: No retained within the recent evidence window direct negative evidence is provided in the reviewed sources.

Why now: There is no usable within the recent evidence window evidence after filtering; the only cited article is older than the March 29, 2026 cutoff and therefore not timely support for a 1 year+ ranking under these reviewed sources' evidence policy.

Caveats: The reviewed sources report zero kept rows after recent evidence window for SatVu. Older funding evidence exists but was dropped by policy, so recency is insufficient for a stronger score.

365
Scale AI
lowweak
Opp 2
Risk 1

Thesis: The risk case is limited by lack of direct adverse evidence in the reviewed sources; the primary risk is evidentiary rather than operational because no retained post-recent evidence window event details, award sizing to the company, or execution milestones are available.

Why now: Why now is muted because the reviewed sources references support article in membership rationale, but no, article summary, or retained evidence after the 90-day filter are available to confirm timing or scope.

Caveats: Despite 273 articles considered, coverage data shows articles after recent evidence window 0 and evidence after recent evidence window 0. The contract claim is only present in membership rationale citing article without a in the served reviewed sources. Opportunity score is kept low because the the evidence standard require direct positive evidence, not just membership inclusion.

366
Schaeffler AG
lowweak
Opp 2
Risk 1

Thesis: No material negative evidence is available within the reviewed sources recent evidence window. Risk remains low on evidence, not necessarily in reality.

Why now: No surviving 90-day evidence are available despite 94 articles considered. The only support is the membership rationale reference to: but the reviewed sources provide no and no retained evidence.

Caveats: Membership rationale is not sufficient directional proof. No direct positive or negative evidence survived the recent evidence window. Industrial-partner status versus core space-company status is unclear from the reviewed sources.

367
SciTec
lowweak
Opp 1
Risk 1

Thesis: No material negative evidence is retained, leaving no evidence-based risk case.

Why now: No current catalyst is established because the reviewed sources retains no company-specific evidence after the 90-day filter.

Caveats: Phase-2 rationale references, but no or retained summary is available in the reviewed sources. Support level is provisional single-article context. No direct company-specific positive or negative evidence remain after recent evidence window.

368
SEALCOIN AG
lowweak
Opp 2
Risk 1

Thesis: No material adverse evidence is retained.

Why now: The membership rationale says SEALCOIN secured strategic investment for space-based blockchain infrastructure leveraging a satellite constellation, tied to article: but no or retained evidence are present after recent evidence window.

Caveats: Only rationale-level description is available; no retained direct evidence row with is supplied. The business category fit is ambiguous in the reviewed sources itself.

369
SEALSQ Corp
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources also provides no retained material adverse evidence, leaving risk unsupported beyond baseline uncertainty.

Why now: There is no usable current evidence because articles after recent evidence window = 0 and evidence after recent evidence window = 0 following the March 29, 2026 cutoff.

Caveats: No surviving recent evidence window-qualified evidence. Space relevance in reviewed sources rationale does not establish direction.

370
SES S.A.
lowweak
Opp 1
Risk 1

Thesis: No material adverse evidence is available for SES. Risk score remains low because of lack of evidence, not because risk has been disproven.

Why now: Why-now is weak because no reviewed evidence are available after recent evidence window, so recency and catalysts cannot be assessed from the reviewed sources.

Caveats: Membership rationale references and, but no corresponding available article summaries or evidence are provided. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. Cohort membership does not establish opportunity.

371
Sidus Space Inc.
lowweak
Opp 1
Risk 1

Thesis: No within the recent evidence window direct negative evidence was available, so the reviewed sources does not support a material risk thesis.

Why now: There is no retained dated company evidence after the 90-day recent evidence window; timing support for a 1 year+ thesis is absent in the reviewed sources.

Caveats: Coverage is effectively empty after recent evidence window: articles after recent evidence window = 0 and evidence after recent evidence window = 0. The membership rationale mentions article IDs, and, but no or retained evidence content are provided in these reviewed sources.

372
SkyFi
lowweak
Opp 1
Risk 1

Thesis: No direct negative evidence is available, so there is no supportable downside thesis from these reviewed sources alone.

Why now: Membership rationale says SkyFi was mentioned as a commercial access partner for Vantor's satellite imagery constellation in article, but this is only contextual and no or direct evidence are provided.

Caveats: Partner context is weaker than direct company evidence. No evidence available after recent evidence filtering. Referenced has no in the reviewed sources.

373
Skyfora
lowweak
Opp 1
Risk 1

Thesis: There is no retained direct adverse evidence in the reviewed sources after recent evidence window, so any risk thesis would be speculative rather than evidence-based.

Why now: No within the recent evidence window company-specific catalyst is provided. The reviewed sources reports zero reviewed evidence after the 90-day cutoff for Skyfora, so recency is insufficiently grounded.

Caveats: Phase-2 rationale references a €6.5M raise tied to: but no representative article, or retained evidence row is provided in these reviewed sources, so it cannot be used as direct scored evidence. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Membership review status is not directional proof.

374
Solestial Inc.
lowweak
Opp 1
Risk 1

Thesis: No material adverse thesis is supportable from these reviewed sources because no retained direct negative evidence is provided inside the recent evidence window.

Why now: No current catalyst can be established from the reviewed sources; the company has zero evidence after recent evidence window.

Caveats: Phase-2 rationale says York Space Systems acquired Solestial and cites: but no article summary or is provided here, so it cannot be used as cited factual support. Coverage debug shows 4 articles considered and 0 article IDs after recent evidence window. Absence of evidence is not positive or negative proof.

375
Solstar Space Company
lowweak
Opp 1
Risk 1

Thesis: No material negative evidence is available, so there is no supported adverse thesis from the evidence provided.

Why now: The reviewed sources contain no reviewed evidence after recent evidence window for this company, preventing a recency-based 1 year+ ranking judgment beyond watchlist status.

Caveats: Membership rationale references article, but no direct summary or evidence row is available here for citation. Coverage debug shows zero available evidence after recent evidence window. Private-company status is not itself positive or negative.

376
Space Mission Systems
lowweak
Opp 2
Risk 1

Thesis: No direct negative evidence is available. The main risk is identity ambiguity and insufficient grounding rather than a demonstrated adverse development.

Why now: The only potential 'why now' is contract-related context in the membership rationale, but it is not sufficiently tied to this entity and no dated scoring evidence with is available.

Caveats: Membership rationale references article ID: but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. Entity identification is unclear in the reviewed sources.

377
Space Systems/Loral, LLC (SSL)
lowweak
Opp 1
Risk 1

Thesis: No direct adverse evidence is available in the reviewed sources, so risk stays low purely due to missing evidence rather than demonstrated resilience.

Why now: No current catalyst can be established because coverage debug shows 0 article IDs after recent evidence window and 0 evidence after recent evidence window. The rationale cites: without a in these reviewed sources.

Caveats: Only industry-report context is referenced in membership rationale. No direct event/fact evidence survived the recent evidence window.

378
Space42
lowweak
Opp 1
Risk 1

Thesis: No retained adverse evidence is provided, so there is no material evidence-based risk thesis in these reviewed sources.

Why now: Why now is weak because coverage data shows no articles after recent evidence window and no evidence after recent evidence window.

Caveats: Membership rationale references article IDs but no are provided, so they cannot be used as cited factual support here. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0.

379
Spaceflux
lowweak
Opp 3
Risk 1

Thesis: No material negative evidence is available. The main risk is that the cited funding amount may be too small to be strategically meaningful, but the reviewed sources does not provide direct adverse evidence or enough detail to rank this as a strong risk name (: not provided in reviewed sources).

Why now: A follow-on investment could matter over 1 year+ if it extends development in debris tracking, but there is no available dated evidence within the recent evidence window and no direct article summary/ in the reviewed sources.

Caveats: Only article-level rationale is available. Funding size may be modest, but reviewed sources does not provide enough context to judge materiality precisely. No representative article or quote available.

380
SpaceLocker
lowweak
Opp 1
Risk 1

Thesis: There is not enough retained evidence in the recent evidence window to support a material risk thesis.

Why now: No article-level or event-level evidence were retained after the March 29, 2026 recent evidence window cutoff; recency for the membership rationale is therefore unusable for ranking.

Caveats: Membership rationale references article, but no representative article summary or retained evidence row is included. Single-article universe with zero retained rows limits confidence materially.